FIELD: biotechnology.
SUBSTANCE: immunogenic modified F protein of human metapneumovirus (hMPV) or a fragment thereof is described, stabilized in a pre-fusion conformation, containing a recombinant single-chain polypeptide that does not contain a fusion peptide (FP) and contains an F2 domain, a heterologous peptide linker and an F1 domain, with the said linker located between specified F2 and F1 domains and contains a cysteine residue that forms a disulfide bond with a non-natural cysteine residue present in the specified F1 domain. Also the following is presented: an immunogenic composition containing an immunogenic protein or a fragment thereof, additionally containing a pharmaceutically acceptable carrier and/or excipient, wherein the said composition can induce neutralizing antibodies that recognize the native hMPV F protein. Also the following is provided: a method of treating or preventing hMPV infection in a human subject, comprising administering to the human subject an immunogenic composition or vaccine containing an immunogenic protein or fragment thereof.
EFFECT: invention expands the arsenal of means for treating or preventing hMPV infection.
12 cl, 13 dwg, 5 tbl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
IMMUNOGLOBULIN WITH ONE VARIABLE DOMAIN AGAINST RSV F-PROTEIN | 2016 |
|
RU2730671C2 |
GLYCOSYLATED FUSED PROTEINS VWF WITH IMPROVED PHARMACOKINETICS | 2017 |
|
RU2782212C2 |
NOVEL FUSION PROTEINS SPECIFIC FOR CD137 AND GPC3 | 2020 |
|
RU2814653C2 |
BISPECIFIC FUSION PROTEIN AND ITS USE | 2021 |
|
RU2801528C2 |
POLYVALENT AND POLYSPECIFIC OX40-BINDING FUSED PROTEINS | 2017 |
|
RU2773052C2 |
EMBODIMENTS OF IGG-Fc FOR USE IN VETERINARY SCIENCE | 2018 |
|
RU2814952C2 |
POLYVALENT AND POLYSPECIFIC GITR-BINDING FUSED PROTEINS | 2016 |
|
RU2753439C2 |
RECOVERED NUCLEIC ACID WHICH CODES FVIII-BDD-BASED FUSION PROTEIN AND HETEROLOGOUS SIGNAL PEPTIDE, AND USE THEREOF | 2022 |
|
RU2818229C2 |
IL-12 HETERODIMERIC FC FUSION PROTEINS | 2019 |
|
RU2819097C2 |
PROTEINS BINDING NKG2D, CD16 AND TUMOUR-ASSOCIATED ANTIGEN | 2018 |
|
RU2816716C2 |
Authors
Dates
2024-01-22—Published
2020-05-19—Filed